(MENAFN- IMARC Group)
IMARC Group, a leading market research company, has recently releases a report titled
“ Women's health Diagnostics
Market: Global industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028. ”
The study provides a detailed analysis of the industry, including the
global
women's health diagnostics
market
size, report, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big is the
Women's Health Diagnostics
Market?
The global women's health diagnostics market size reached US$ 23.6 Billion in 2022 . Looking forward, IMARC Group expects the market to reach US$ 37.3 Billion by 2028 , exhibiting a growth rate (CAGR) of 7.51% during 2023-2028.
What is Women's Health Diagnostics ?
Women's health diagnostics refers to the comprehensive and evolving field of medical assessments and tests specifically tailored to monitor, diagnose, and maintain the well-being of women. It encompasses a broad spectrum of healthcare procedures and examinations that address the health concerns and needs of women. It also involves wellness screenings and preventative measures like regular check-ups, cholesterol checks, and blood pressure monitoring. It facilitates the early detection and prevention of various diseases, which include breast cancer, cervical cancer, ovarian cancer, and uterine fibroids. It aids in the management of chronic conditions that disproportionately affect women, such as polycystic ovary syndrome (PCOS) and endometriosis.
For an in-depth analysis, you can refer sample copy of the report:
Women's Health Diagnostics
Market
Demand, Industry Trends:
The increasing prevalence of several chronic diseases among the female population represents one of the key factors positively influencing the market. Additionally, the rising number of women entering menopause and facing age-related health challenges, such as osteoporosis and cardiovascular disease, driving the demand for diagnostic services is driving the demand for diagnostic services. Along with this, the growing emphasis on preventive healthcare is encouraging women to seek regular check-ups and screenings.
Apart from this, ongoing advancements in diagnostic technologies and the development of digital mammography, three-dimensional (3D) ultrasounds, and non-invasive prenatal testing are becoming more accessible and accurate, leading to earlier and more precise diagnoses. These technological innovations are enhancing patient outcomes and improving the overall healthcare experience for women. Moreover, women are actively seeking information about their health and advocating for comprehensive diagnostic evaluations, which is strengthening the growth of the market.
Furthermore, various healthcare companies and research institutions are investing heavily in the development of innovative diagnostic tests and technologies specifically tailored to the health needs of women. These ongoing research and development (R&D) activities are expanding the range of available diagnostic options and improving their accuracy. Along with this, the governing authorities of various countries are undertaking initiatives and introducing policies that focus on women's health, such as breast cancer screening programs and subsidized preventive services.
Leading Companies Operating in the Global Women's Health Diagnostics Industry:
Abbott Laboratories Becton Dickinson and Company bioMérieux SA Cardinal Health Inc. Cook Group Incorporated F. Hoffmann-La Roche AG General Electric Company Hologic Inc. Koninklijke Philips N.V. Perkinelmer Inc. Quest Diagnostics Inc. Siemens AG Thermo Fisher Scientific Inc.
Women's Health Diagnostics Market Report Segmentation: The report has segmented the market into the following categories:
Breakup by Type:
o
Biopsy Device
o
Imaging and Monitoring Devices
o
Accessories and Consumables
o
Breast Cancer Testing
o
PAP Smear and HPV Test
o
Pregnancy Testing and Ovulation Testing
o
Others
Breakup by Application:
Breast Cancer Infectious Disease Testing Osteoporosis Testing Pregnancy and Fertility Testing Sexually Transmitted Disease Testing Others
Breakup by End User:
Hospital and Diagnostics Centers Home Care
Breakup by Region:
North America: (United States, Canada) Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others) Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others) Latin America: (Brazil, Mexico, Others) Middle East and Africa
Key highlights of the report:
Market Performance Market Outlook Porter's Five Forces Analysis Market Drivers and Success Factors SWOT Analysis Value Chain Comprehensive Mapping of the Competitive Landscape
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company's expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email:
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
MENAFN15022024004122016232ID1107854670
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.